|
Poster session one (odd numbers)
Wednesday 15 July 17:30 – 19:00
P001 Moxifloxacin increases anti-tumour/anti-angiogenic activity of irinotecan in human xenograft tumours
D. Reuveni, D. Halperin, I. Shalit, G. Tsarfaty and I. Fabian
P003 The role of RhoJ in endothelial cell biology and angiogenesis
S. Kaur, S. Hiltbrunner, J. Herbert, R. Bicknell and V.L. Heath
P005 Hydrogen sulfide stimulates angiogenesis
A. Pyriochou, A. Marazioti, R. Wang, C. Szabo and A. Papapetropoulos
P007 Identification of the pro-angiogenic capacity of neurotrophin-3
B. Cristofaro, A. Caporali, O.A. Stone, D. Dawbarn, M. Meloni, P. Madeddu, D.O. Bates
P009 Immune responses to the tumour endothelial marker Robo4
F. Ahmed, X. Zhuang, N.M. Steven, J.C. Steele and R. Bicknell
P011 Soluble form of notch ligand Delta-like4 impairs the inflammatory-induced angiogenesis process in hind-limb ischemia model
A. Al Haj Zen, M. Bazan-Peregrino and P. Madeddu
P013 Application of kinome profiling technology to selectively measure VEGF receptor activity
A.H. Sikkema, E.S.J.M. de Bont, S.H. Diks, A. ter Elst, R. Ruijtenbeek, P.J. Boender, R. de Wijn,
P015 Abstract withdrawn
N/A
P017 FoxO transcription factors as regulators of CTGF expression by hypoxia
J. Samarin and M. Goppelt-Struebe
P019 Role for talin in embryonic angiogenesis
S. Monkley, L. Spence and D. Critchley
P021 Hypoxia and the pathogenesis of rheumatoid arthritis (RA): predominant role for HIF-1alpha in the induction of hypoxia-dependent responses in RA fibroblasts
B. Muz, H. Larsen, S. Kiriakidis and E. Paleolog
P023 Characterization of a novel protein kinase D inhibitor in endothelial cells
I.M. Evans, A. Bagherzadeh, M. Charles, T. Raynham, L. Kelland and I. Zachary
P025 Integrative study and preclinical characterization of new multi-targeted drugs disrupting tumour angiogenesis, inflammation and/or invasive/metastatic potential
B. Martínez-Poveda, E. Melgarejo, C. Cárdenas, M.V. Ruiz-Pérez, M. García-Caballero,
P027 EDF-1 contributes to the regulation of nitric oxide release in VEGF-treated endothelial cells
M. Leidi, M. Mariotti and J.A.M. Maier
P029 Proliferation, phospholipases and angiogenesis: how do they fit together?
A.F. Odell, S. Ponnambalam and J.H. Walker
P031 Reduced NFAT-dependent VEGFR-1 expression causes abnormal VEGF signalling in haemangiomas
E. Boye, M. Jinnin and B. Olsen
P033 The role of endocytic trafficking in Tie2 signalling
E. Maxwell, M. Marron and E. Smythe
P035 The effect of high VEGFA levels in AML outgrowth: an important role for the environment
A.C. Weidenaar, A. ter Elst, H.J.M. de Jonge, T. Meeuwsen-de Boer, W.A. Kamps and E.S.J.M. de Bont
P037 Butyrate suppresses expression of neuropilin-1 and VEGF through inhibition of Sp1 activation
C.-W. Yu, J.S. Waby, H. Chirakkal, C.A. Staton and B.M. Corfe
P039 Endothelial thymosin Beta4 acts during vascular development to facilitate mural cell recruitment to the vessel wall
A. Rossdeutsch, N. Smart, M. Turner and P.R. Riley
P041 Escape from breast cancer therapy: are neuropilins the key?
S. Lunj, C.A. Staton, I. Holen, M.W. Reed and N.J. Brown
P043 Tissue factor inhibition suppresses breast tumour growth
J.E. Bluff, M. Amarzguioui, J. Slattery, N.J. Brown, M.W.R. Reed and C.A. Staton
P045 The VEGF/VEGFR and Ang/Tie axes have opposing roles in pericyte recruitment following
O.A. Stone, S.J. Harper and D.O. Bates
P047 IL-10 mediates induced and constitutive macrophage VEGF production
W.-K. Wu, D.O. Bates, L.B. Nicholson and A.D. Dick
P049 Neuropilin-1 cross-talk with PDGF receptors
S.G. Ball, A. Shuttleworth and C.M. Kielty
|
|
Poster session two (even numbers)
Thursday 16 July 12:45 – 14:00
P002 Nitric oxide synthase inhibitors regulate VEGF-mediated angiogenesis
L.R. Fiedler, T. Bachetti, J. Leiper, I. Zachary and B. Wojciak-Stothard
P004 Neuropilin-1 mediates PDGF migration and signalling in human coronary artery vascular smooth muscle cells
C. Pellet-Many, P. Frankel, I. Evans and I. Zachary
P006 VEGF receptor expression in endothelial cells in response to hypoxia
C. Ulyatt, J. Walker and S. Ponnambalam
P008 Stat3 is important for oxidative-induced VEGF secretion
A. Klettner, T. Berg and J. Roider
P010 Monomeric C-reactive protein expressed by angiogenic neovessels in stroked brain tissue is a potent activator of angiogenesis in vitro
M. Slevin, S. Matou, M.M. Turu, A. Luque, N. Rovira, L. Badimon and J. Krupinski
P012 Kinome profiling as an indicator for the angiogenic status of low-grade paediatric astrocytomas
A.H. Sikkema, E.S.J.M. de Bont, G. Molema, P.J. Zwiers, S.H. Diks, A. Dimberg, W.A. Kamps,
P014 Inhibition of VEGFR2 dimerization, a novel mechanism of inhibiting VEGFR2 signalling
J. Kendrew, J.S. Kang, C. Eberlein, I. Foltz, B. Hedberg, J. Zhou, K. McDaid, H.M. Weir and S.T. Barry
P016 Beta-adrenoceptors can modulate endothelial cell migration, proliferation, tubule formation and wound angiogenesis
A.P. O’Leary and C.E. Pullar
P018 Identification and characterization of a novel anti-angiogenic and anti-tumorigenic peptide derived from the C-terminus of TIMP-3
Y.-Y. Chen, M. Muthana, N. Brown, C. Lewis and M. Barker
P020 Proteolysis and GTPase regulation of endothelial VEGFR2 signalling
A. Bruns, L. Bao, H.M. Jopling, A.F. Odell, J.H. Walker and S. Ponnambalam
P022 Regulation of VEGF-induced endothelial migration via a novel neuropilin 1- p130Cas signalling pathway
I. Evans, P. Frankel and I. Zachary
P024 ERK5 regulates VEGF-mediated cell survival and tubular morphogenesis in primary human microvascular endothelial cells
O. Roberts, K. Holmes, J. Müller, D. Cross and M. Cross
P026 The role of neuropilin-1 expression in endothelial progenitor cell differentiation
M. Junemann-Ramirez, P. Lehtolainen, J.F. Martin, M. Yates, S. Querol, R. Horton, S.G. Gomez,
P028 Small-molecule modulators of HIF-1 and HIF-2 dimerization; new tools for probing the protein interaction network of angiogenesis
K. Nordgren and A. Tavassoli
P030 Nerve growth factor (NGF) promotes vascular regeneration and protection after
M. Meloni, A. Caporali and C. Emanueli
P032 Vascular maturity – impact on the tumour microenvironment and therapeutic exploitation
S.J. Lunt, P. Sarangi and G. Tozer
P034 The role of RCAN1 in VEGFR-2-mediated angiogenesis
K. Holmes, E. Chapman and M. Cross
P036 Human vein-derived progenitors give rise to pericyte-like cells supporting in vitro and in vivo angiogenesis
P. Campagnolo, A. Al Haj Zen, N. Kraenkel, R. Katare, A.P. Beltrami, D. Cesselli, G. Angelini
P038 Macrophages and tumour revascularization following treatment with vascular-disrupting agents
A.F. Welford, S. Coffelt, C.E. Lewis and G.M. Tozer
P040 VE-cadherin suppresses sprouting via signalling to MLC2 phosphorylation
S. Abraham, M. Yeo, M. Montero-Balaguer, H. Paterson, E. Dejana, C.J. Marshall and G. Mavria
P042 The relationship between angiogenesis, vascular endothelial growth factor and its receptors in human surgical wounds
C.A. Staton, I. Kumar, S.S. Cross, M.W.R. Reed and N.J. Brown
P044 Modulation of tumour angiogenesis by targeting p38 MAPK signalling in tumour-associated macrophages
C.A.C. Hyde, S. Kumar, R. Steiner and R.A. Schwendener
P046 Molecular dissection of blood vessel growth and maturation during angiogenesis
R. Daniel, M. Fisher, M.V. Flores-Merino, C. Lo-Presti, G. Battaglia, J. Jurgensmeier, A. Ryan
P048 Arterial/venous segregation by selective cell sprouting
S.P. Herbert, J. Huisken, T.N. Kim, M.E. Feldman, R.A. Wang, K.M. Shokat and D.Y.R. Stainier
|